Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitlePalivizumab immunoprophylaxis for infants with BPD has medium- and long-term benefits: myth or maxim?AuthorsQuinn, Lauren A.; Hirani, Sunaya H.; Williams, Thomas C.; Sinha, Ian P.SubjectsBRONCHOPULMONARY dysplasia prevention; EVALUATION of medical care; PREMATURE infants; PREVENTIVE health services; TREATMENT effectiveness; PALIVIZUMAB; BRONCHIOLE diseases; BRONCHOPULMONARY dysplasiaPublicationBreathe, 2021, Vol 17, Issue 4, p1ISSN1810-6838Publication typeArticleDOI10.1183/20734735.0110-2021